SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 43 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $57,000 | -36.7% | 215,518 | -1.3% | 0.00% | – |
| Q1 2020 | $90,000 | +20.0% | 218,268 | -1.0% | 0.00% | – |
| Q4 2019 | $75,000 | -52.8% | 220,406 | -0.1% | 0.00% | – |
| Q3 2019 | $159,000 | +32.5% | 220,670 | +33.1% | 0.00% | – |
| Q2 2019 | $120,000 | -7.7% | 165,769 | +54.8% | 0.00% | – |
| Q1 2019 | $130,000 | +333.3% | 107,116 | +51.3% | 0.00% | – |
| Q4 2018 | $30,000 | -78.9% | 70,820 | +0.3% | 0.00% | – |
| Q3 2018 | $142,000 | -1.4% | 70,586 | +3.7% | 0.00% | – |
| Q2 2018 | $144,000 | -20.4% | 68,045 | +2.1% | 0.00% | – |
| Q1 2018 | $181,000 | -27.0% | 66,678 | -0.7% | 0.00% | – |
| Q4 2017 | $248,000 | +313.3% | 67,170 | +117.7% | 0.00% | – |
| Q3 2017 | $60,000 | -28.6% | 30,850 | +0.1% | 0.00% | – |
| Q2 2017 | $84,000 | -34.4% | 30,817 | -1.6% | 0.00% | – |
| Q1 2017 | $128,000 | +47.1% | 31,329 | +29.6% | 0.00% | – |
| Q4 2016 | $87,000 | +26.1% | 24,178 | +54.1% | 0.00% | – |
| Q3 2016 | $69,000 | – | 15,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,133,583 | $4,104,000 | 3.61% |
| GREAT POINT PARTNERS LLC | 1,537,873 | $5,567,000 | 1.14% |
| BVF INC/IL | 1,392,720 | $5,042,000 | 1.01% |
| Boxer Capital, LLC | 525,000 | $1,901,000 | 0.74% |
| Vivo Capital, LLC | 500,000 | $1,810,000 | 0.60% |
| Healthcare Value Capital, LLC | 150,000 | $543,000 | 0.58% |
| Cormorant Asset Management, LP | 1,000,000 | $3,620,000 | 0.49% |
| Telemetry Investments, L.L.C. | 120,807 | $437,000 | 0.25% |
| Palo Alto Investors LP | 1,162,473 | $4,208,000 | 0.24% |
| NEA Management Company, LLC | 1,298,274 | $4,700,000 | 0.19% |